The Neurocognitive Bases of Trust in Intellectual Disability

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-29
SponsorHospices Civils de Lyon

About this trial

This project studies the neurocognitive basis of trust adjustment in intellectual disability (ID), a source of significant vulnerability for these patients, focusing on two target populations chosen for their specific social characteristics: people with Down syndrome, who are often described as being hypersocial, and people with Fragile X syndrome, who are often characterized by a completely opposite social behaviour profile, with a withdrawn attitude and significant social anxiety.

The three different types of mechanisms that contribute to the adjustment of interpersonal trust: affective evaluation, trait attribution, and epistemic evaluation of informants, will be studied. Affective evaluation processes recruit subcortical structures such as the amygdala and assess potential social threats in the environment. The second mechanism for selecting whom to trust consists of forming a representation of a person's dispositions, such as benevolence and competence (also known as traits), and using it to predict that person's future behaviour. Trait attribution processes recruit a cortico-cerebellar network comprising the mPFC, CRUS I and posterior lobule VI. The third mechanism, called epistemic vigilance, allows to adjust our trust in what others communicate to us. This mechanism involves linking the assessment of the reliability of individuals who communicate (based on their benevolence and competence) with the reliability of the communicated information. Epistemic assessment involves frontal areas and areas associated with the representation of mental states in order to enable the evaluation of the truthfulness of the communicated information. All of these mechanisms become functional very early on, before a child's sixth birthday. There are reasons to expect that several of these central mechanisms supporting selective trust will behave atypically in intellectual disability.

Eligibility criteria

Qualifiers

Complete chromosomal trisomy of the 21st chromosome confirmed by karyotype analysis

Aged 13 to 29 (chronological age)

French as their native language

Having signed an informed consent form and/or whose legal guardians/patient representatives have signed the informed consent form

Disqualifiers

Inability to understand tasks

Significant brain malformation

Uncontrolled epilepsy

Significant hearing impairment

Trial design

Treatments tested in this trial

  • Confidence adjustment assessment
  • clinical assessment
  • Cognitive assessment
  • Executive function assessment
  • Sociability assessment
  • Brain MRI (structural and functional)

Treatment groups

112 Participants
are divided into 4 treatment groups

Sponsors and collaborators